96 related articles for article (PubMed ID: 1371075)
1. Molecular interaction between HIV-1 major envelope glycoprotein and dextran sulfate.
Mbemba E; Chams V; Gluckman JC; Klatzmann D; Gattegno L
Biochim Biophys Acta; 1992 Jan; 1138(1):62-7. PubMed ID: 1371075
[TBL] [Abstract][Full Text] [Related]
2. Conglutinin binds the HIV-1 envelope glycoprotein gp 160 and inhibits its interaction with cell membrane CD4.
Andersen O; Sørensen AM; Svehag SE; Fenouillet E
Scand J Immunol; 1991 Jan; 33(1):81-8. PubMed ID: 1996409
[TBL] [Abstract][Full Text] [Related]
3. The interaction of a glycosaminoglycan, heparin, with HIV-1 major envelope glycoprotein.
Mbemba E; Czyrski JA; Gattegno L
Biochim Biophys Acta; 1992 Dec; 1180(2):123-9. PubMed ID: 1281430
[TBL] [Abstract][Full Text] [Related]
4. Dextran sulfate blocks antibody binding to the principal neutralizing domain of human immunodeficiency virus type 1 without interfering with gp120-CD4 interactions.
Callahan LN; Phelan M; Mallinson M; Norcross MA
J Virol; 1991 Mar; 65(3):1543-50. PubMed ID: 1995952
[TBL] [Abstract][Full Text] [Related]
5. Carbohydrate binding properties of the envelope glycoproteins of human immunodeficiency virus type 1.
Haidar M; Seddiki N; Gluckman JC; Gattegno L
Glycoconj J; 1992 Dec; 9(6):315-23. PubMed ID: 1284814
[TBL] [Abstract][Full Text] [Related]
6. HIV-1 gp41 contains two sites for interaction with several proteins on the helper T-lymphoid cell line, H9.
Chen YH; Ebenbichler C; Vornhagen R; Schulz TF; Steindl F; Böck G; Katinger H; Dierich MP
AIDS; 1992 Jun; 6(6):533-9. PubMed ID: 1388873
[TBL] [Abstract][Full Text] [Related]
7. (Patho)physiologic pathways to drug targeting: artificial viral envelopes.
Schreier H; Ausborn M; Günther S; Weissig V; Chander R
J Mol Recognit; 1995; 8(1-2):59-62. PubMed ID: 7541229
[TBL] [Abstract][Full Text] [Related]
8. Interactions of HIV-1 envelope glycoproteins with derivatized dextrans.
Carré V; Mbemba E; Letourneur D; Jozefonvicz J; Gattegno L
Biochim Biophys Acta; 1995 Feb; 1243(2):175-80. PubMed ID: 7532999
[TBL] [Abstract][Full Text] [Related]
9. Lectin-carbohydrate interactions and infectivity of human immunodeficiency virus type 1 (HIV-1).
Gattegno L; Ramdani A; Jouault T; Saffar L; Gluckman JC
AIDS Res Hum Retroviruses; 1992 Jan; 8(1):27-37. PubMed ID: 1736938
[TBL] [Abstract][Full Text] [Related]
10. Interactions of HIV-1 and HIV-2 envelope glycoproteins with sulphated polysaccharides and mannose-6-phosphate.
Mbemba E; Gluckman JC; Gattegno L
Glycobiology; 1994 Feb; 4(1):13-21. PubMed ID: 8186546
[TBL] [Abstract][Full Text] [Related]
11. Properties of HIV membrane reconstituted from its recombinant gp160 envelope glycoprotein.
Cornet B; Decroly E; Thines-Sempoux D; Ruysschaert JM; Vandenbranden M
AIDS Res Hum Retroviruses; 1992 Oct; 8(10):1823-31. PubMed ID: 1457195
[TBL] [Abstract][Full Text] [Related]
12. Anti-CD4 anti-idiotype antibodies in volunteers immunized with rgp160 of HIV-1 or infected with HIV-1.
Keay S; Tacket CO; Murphy JR; Handwerger BS
AIDS Res Hum Retroviruses; 1992 Jun; 8(6):1091-8. PubMed ID: 1503823
[TBL] [Abstract][Full Text] [Related]
13. Study of the interaction of HIV-1 and HIV-2 envelope glycoproteins with the CD4 receptor and role of N-glycans.
Bahraoui E; Benjouad A; Guetard D; Kolbe H; Gluckman JC; Montagnier L
AIDS Res Hum Retroviruses; 1992 May; 8(5):565-73. PubMed ID: 1515210
[TBL] [Abstract][Full Text] [Related]
14. Artificial viral envelopes containing recombinant human immunodeficiency virus (HIV) gp160.
Chander R; Schreier H
Life Sci; 1992; 50(7):481-9. PubMed ID: 1371818
[TBL] [Abstract][Full Text] [Related]
15. Calcium requirement and inhibitor spectrum for intracellular HIV type 1 gp160 processing in cultured HeLa cells and CD4+ lymphocytes: similarity to those of viral envelope glycoprotein maturase.
Kamoshita K; Shiota M; Sasaki M; Koga Y; Okumura Y; Kido H
J Biochem; 1995 Jun; 117(6):1244-53. PubMed ID: 7490267
[TBL] [Abstract][Full Text] [Related]
16. Glycosylation and stability of mature HIV envelope glycoprotein conformation under various conditions.
Papandreou MJ; Idziorek T; Miquelis R; Fenouillet E
FEBS Lett; 1996 Jan; 379(2):171-6. PubMed ID: 8635586
[TBL] [Abstract][Full Text] [Related]
17. Lymphoproliferative responses to mitogens and HIV-1 envelope glycoprotein among volunteers vaccinated with recombinant gp160.
Tacket CO; Baqar S; Munoz C; Murphy JR
AIDS Res Hum Retroviruses; 1990 Apr; 6(4):535-42. PubMed ID: 2187503
[TBL] [Abstract][Full Text] [Related]
18. Membrane anchorage of gp160 is necessary and sufficient to prevent CD4 transport to the cell surface.
Martin RA; Nayak DP
Virology; 1996 Jun; 220(2):473-9. PubMed ID: 8661397
[TBL] [Abstract][Full Text] [Related]
19. Sulfated polyanions prevent HIV infection of lymphocytes by disruption of the CD4-gp120 interaction, but do not inhibit monocyte infection.
Lynch G; Low L; Li S; Sloane A; Adams S; Parish C; Kemp B; Cunningham AL
J Leukoc Biol; 1994 Sep; 56(3):266-72. PubMed ID: 7521897
[TBL] [Abstract][Full Text] [Related]
20. Anti-CD4 antibodies generated in response to HIV-1 rgp160 immunization of HIV-1-infected chimpanzees.
Keiser P; Fernie B; Tacket C; Wecksler W; Keay S
AIDS; 1993 Jan; 7(1):136-8. PubMed ID: 8442909
[No Abstract] [Full Text] [Related]
[Next] [New Search]
